BB
BB Biotech Portfolio holdings
AUM
$3.98B
This Quarter Return
+5.05%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
–
AUM
$2.53B
AUM Growth
+$2.53B
(+0.68%)
Cap. Flow
+$23M
Cap. Flow
% of AUM
0.91%
Top 10 Holdings %
Top 10 Hldgs %
72.66%
Holding
32
New
3
Increased
6
Reduced
2
Closed
2
Top Buys
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$27.2M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$16.9M |
| 3 |
MacroGenics
MGNX
|
$14M |
| 4 |
Agios Pharmaceuticals
AGIO
|
$8.52M |
| 5 |
Ionis Pharmaceuticals
IONS
|
$7.57M |
Top Sells
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
$35.6M |
| 2 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
$14.2M |
| 3 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$10.1M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$6.3M |
Sector Composition
| 1 | Healthcare | 85.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CELG
1
DELISTED
Celgene Corp
CELG
| $356M | 14.05% |
3,609,298
| – | – |
|
2
Incyte
INCY
$16.5B
| $307M | 12.12% |
3,840,406
| – | – |
|
3
Gilead Sciences
GILD
$140B
| $231M | 9.14% |
2,774,596
| – | – |
|
|
4
Ionis Pharmaceuticals
IONS
$6.79B
| $165M | 6.53% |
7,104,838
+325,000
| +5% | +$7.57M |
|
|
RDUS
5
DELISTED
Radius Health, Inc.
RDUS
| $160M | 6.33% |
4,360,399
| – | – |
|
6
Neurocrine Biosciences
NBIX
$13.8B
| $142M | 5.6% |
3,121,552
| – | – |
|
|
ALXN
7
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $138M | 5.44% |
1,179,428
+145,000
| +14% | +$16.9M |
|
8
Vertex Pharmaceuticals
VRTX
$100B
| $122M | 4.81% |
1,415,445
+50,000
| +4% | +$4.3M |
|
|
MDVN
9
DELISTED
MEDIVATION, INC.
MDVN
| $120M | 4.74% |
1,991,112
-590,000
| -23% | -$35.6M |
|
|
10
Agios Pharmaceuticals
AGIO
$2.19B
| $99M | 3.91% |
2,363,321
+203,400
| +9% | +$8.52M |
|
|
TSRO
11
DELISTED
TESARO, Inc.
TSRO
| $97M | 3.83% |
1,154,582
-75,000
| -6% | -$6.3M |
|
12
Regeneron Pharmaceuticals
REGN
$61.5B
| $71.6M | 2.83% |
205,000
| – | – |
|
13
Alnylam Pharmaceuticals
ALNY
$58.5B
| $66.1M | 2.61% |
1,191,338
| – | – |
|
14
Halozyme
HALO
$8.56B
| $63.7M | 2.51% |
7,379,832
| – | – |
|
15
Novavax
NVAX
$1.21B
| $60.6M | 2.39% |
8,330,000
| – | – |
|
|
JUNO
16
DELISTED
Juno Therapeutics, Inc.
JUNO
| $50.2M | 1.98% |
1,305,000
| – | – |
|
|
ALDR
17
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $42.1M | 1.66% |
1,685,150
+175,000
| +12% | +$4.37M |
|
|
KITE
18
DELISTED
Kite Pharma, Inc.
KITE
| $37.5M | 1.48% |
750,000
| – | – |
|
|
ICPT
19
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $36.5M | 1.44% |
255,719
| – | – |
|
|
CEMP
20
DELISTED
Cempra, Inc.
CEMP
| $33.7M | 1.33% |
2,041,900
| – | – |
|
|
ITCI
21
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $27.2M | 1.07% |
+700,000
| New | +$27.2M |
|
|
SAGE
22
DELISTED
Sage Therapeutics
SAGE
| $25.6M | 1.01% |
850,639
+16,976
| +2% | +$511K |
|
|
23
MacroGenics
MGNX
$112M
| $14M | 0.55% |
+520,000
| New | +$14M |
|
24
Puma Biotechnology
PBYI
$254M
| $12.9M | 0.51% |
431,991
| – | – |
|
25
Prothena Corp
PRTA
$441M
| $12.2M | 0.48% |
350,000
| – | – |
|